NCT01380769 2020-05-28
A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer
Lumos Pharma
Phase 2 Completed
Clinical Trials
3 trialsNCT01652079 2018-07-02
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT01612546 2018-02-01
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery
City of Hope Medical Center
Phase 2 Completed